Last updated: 2026-09-23 20:13:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $61.16, with a market capitalization of $127.91B and a P/E ratio of 13.70. Over the past 52 weeks, its price has ranged from $42.52 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$127.91B | |
$62.31 | |
$81.44 | |
$16.00 | |
$62.25 | |
7.43M | |
11.12M | |
13.70 | |
$68.64 | |
$42.52 | |
4.01% | |
-- |
Bristol-Myers Squibb Co. (BMY) is trading at $61.24 in after-hours trading as of 2026-09-23 19:56:57, down 1.62% ($1.01) from the regular-session close of $62.25.
After-hours trading shows how investors are pricing BMY after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $64.10 to $61.16, representing a decline of 4.59% ($2.94).
The stock traded between $61.09 and $65.29 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 13.93 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 71.4%
BMY is currently trading at $61.16, placing it 71.4% of the way from its 52-week low of $42.52 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.